Overview
India’s Ministry of Commerce and Industry issued a statement on Saturday indicating that roughly 45% of Indian exports destined for the United States will be exempt from the latest 10% additional tariff imposed by Washington last week. The exemption covers a range of products, specifically generic medicines, smartphones, steel, aluminium and auto parts, which the ministry says will give Indian exporters a competitive advantage as global trade barriers rise.
Tariff Impact
The remaining 55% of Indian export shipments to the United States will be subject to the extra 10% duty. Despite this, the ministry highlighted that India’s overall tariff rates remain lower than those applied to many other economies covered by the U.S. measures.
Trade Negotiations Context
Trade discussions between New Delhi and Washington have been ongoing since the previous year. A preliminary agreement reached in February had envisaged an 18% tariff on Indian goods, but subsequent legal developments in the United States—including a Supreme Court ruling that invalidated President Trump’s reciprocal tariff framework—have altered the landscape. India is continuing negotiations with the aim of concluding a broader bilateral trade agreement at an early stage.
Sector‑Specific Concerns
The announcement comes amid heightened concerns over potential U.S. tariffs on generic medicines, a sector where the United States represents India’s largest export market. Indian pharmaceutical firms have been closely monitoring the situation. Additionally, India rejected recent suggestions that it could face higher tariffs on labour‑related grounds, arguing that the United States had not provided evidence of inadequate safeguards against forced labour.
Outlook
The exemptions are expected to provide immediate relief to exporters in the highlighted sectors while the broader trade talks proceed. The ministry’s statement underscores that, although a portion of exports will still incur the additional duty, India’s tariff positioning remains comparatively favourable.